In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
Cidara Therapeutics Inc (NASDAQ: CDTX) closed the day trading at $98.5 up 2.24% from the previous closing price of $96.34. In other words, the price has increased by $2.24 from its previous closing price. On the day, 1.08 million shares were traded. CDTX stock price reached its highest trading level at $101.885 during the session, while it also had its lowest trading level at $96.34.
Ratios:
For a better understanding of CDTX, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 16.45 and its Current Ratio is at 16.45. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
On March 12, 2025, Citizens JMP started tracking the stock assigning a Mkt Outperform rating and target price of $46.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 11 ’25 when Davarpanah Nicole Negar sold 474 shares for $62.86 per share. The transaction valued at 29,797 led to the insider holds 31,418 shares of the business.
RA CAPITAL MANAGEMENT, L.P. bought 2,272,727 shares of CDTX for $99,999,988 on Jun 26 ’25. The Director now owns 3,365,523 shares after completing the transaction at $44.00 per share. On Jun 02 ’25, another insider, Mineo Chrysa, who serves as the Director of the company, bought 2,270 shares for $21.71 each. As a result, the insider paid 49,281 and bolstered with 2,270 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CDTX now has a Market Capitalization of 2497768192 and an Enterprise Value of 1989526016.
Stock Price History:
The Beta on a monthly basis for CDTX is 1.32, which has changed by 8.036697 over the last 52 weeks, in comparison to a change of 0.16766965 over the same period for the S&P500. Over the past 52 weeks, CDTX has reached a high of $100.49, while it has fallen to a 52-week low of $10.14. The 50-Day Moving Average of the stock is 43.86%, while the 200-Day Moving Average is calculated to be 166.84%.
Shares Statistics:
Over the past 3-months, CDTX traded about 724.97K shares per day on average, while over the past 10 days, CDTX traded about 1572460 shares per day. A total of 23.23M shares are outstanding, with a floating share count of 19.37M. Insiders hold about 23.61% of the company’s shares, while institutions hold 84.52% stake in the company. Shares short for CDTX as of 1757894400 were 2194099 with a Short Ratio of 3.03, compared to 1755216000 on 2081857. Therefore, it implies a Short% of Shares Outstanding of 2194099 and a Short% of Float of 8.66.
Earnings Estimates
The firm’s stock currently is rated by 6.0 analysts. The consensus estimate for the next quarter is -$1.5, with high estimates of -$0.82 and low estimates of -$2.03.
Analysts are recommending an EPS of between -$4.0 and -$6.99 for the fiscal current year, implying an average EPS of -$6.01. EPS for the following year is -$7.85, with 6.0 analysts recommending between -$3.9 and -$13.55.
